微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030820 Size: 4 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030821 Size: 4 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030822 Size: 4 KB 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-028923 Act: 33 Size: 6 KB 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-028916 Act: 33 Size: 4 KB 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-028917 Act: 33 Size: 4 KB 网页链接
$Myomo(MYO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-028326 Act: 34 Size: 9 MB 网页链接
$Myomo(MYO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-027949 Act: 34 Size: 626 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026872 Size: 4 KB 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-025160 Act: 33 Size: 6 KB 网页链接